Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (BEIGF) Notes Payables (2017 - 2025)

Historic Notes Payables for BeOne Medicines (BEIGF) over the last 4 years, with Q3 2025 value amounting to $813.3 million.

  • BeOne Medicines' Notes Payables changed N/A to $813.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $813.3 million, marking a year-over-year change of. This contributed to the annual value of $851.5 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, BeOne Medicines' Notes Payables is $813.3 million.
  • In the past 5 years, BeOne Medicines' Notes Payables registered a high of $851.5 million during Q4 2024, and its lowest value of $813.3 million during Q3 2025.